IL17A and asthma: We provide evidence that IL-17-dependent signalling in asthma is disease-dependent rather than ICS-dependent, and demonstrate downregulation of canonical markers of T2 inflammation, implying that homeostasis in health involves tonic T2 signalling in the airway mucosa, which is exquisitely sensitive to ICS.